(Q40230167)

English

Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology

scientific article published on September 2006

Statements

Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology (English)
0 references
Kai Temming
Marie Lacombe
Paul van der Hoeven
Teresa Gonzalo
Eli C F Dijkers
Gyorgy Kéri
Klaas Poelstra
Robbert J Kok
1 September 2006
1246-1255

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit